YL
Yuxuan Liu, PhD
Stanford University, Columbia University, University of Groningen, Peking University, Memorial Sloan Kettering Cancer Center
0000-0003-4426-9290
Employment
-
Stanford University Senior Research Scientist2019 - Present
-
Columbia University Associate Research Scientist2016 - 2019
-
Memorial Sloan Kettering Cancer Center Postdoctoral Research Fellow2014 - 2016
Education
-
University of Groningen PhD2011 - 2013
-
Peking University MSc2008 - 2011
-
Peking University BSc2004 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- DHODH as a targetable metabolic Achilles’ heel for chemotherapy-resistant B-ALL Save
- Immunoglobulin variable gene diversity reflects distinct metabolic/signaling states and impacts measurable residual disease monitoring and clinical outcome in B cell acute lymphoblastic leukemia Save
- Integrated N-Glycoproteomic and Phosphoproteomic Profiling Reveals Glycosylation Dysregulation in Relapse-Prone B-ALL Cells Save
- IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies. Save
- Uridine Metabolism as a Targetable Metabolic Achilles’ Heel for chemo-resistant B-ALL Save
- Enrichment in Metabolic Pathway Activation Corresponds to Immunoglobulin Gene Diversity across B Cell Developmental Stages in B-Lymphoblastic Leukemia Save
- Prior Knowledge Integration Improves Relapse Prediction and Identifies Relapse Associated Mechanisms in Childhood B Cell Acute Lymphoblastic Leukemia Save
- Uridine Synthesis Is the Metabolic Vulnerability in Relapse-Associated B-ALL Cells with Active Pre-BCR Signaling Save
- Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia. Save
- Single-cell technologies uncover intra-tumor heterogeneity in childhood cancers. Save